Yarlagadda S. Babu
2013
In 2013, Yarlagadda S. Babu earned a total compensation of $1.1M as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, a 87% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $71,712 |
|---|---|
| Option Awards | $673,965 |
| Salary | $341,486 |
| Stock Awards | $24,140 |
| Other | $12,750 |
| Total | $1,124,053 |
Babu received $674K in option awards, accounting for 60% of the total pay in 2013.
Babu also received $71.7K in non-equity incentive plan, $341.5K in salary, $24.1K in stock awards and $12.8K in other compensation.
Rankings
In 2013, Yarlagadda S. Babu's compensation ranked 6,098th out of 12,286 executives tracked by ExecPay. In other words, Babu earned more than 50.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,098 out of 12,286 | 50th |
Division Manufacturing | 2,127 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 631 out of 1,462 | 57th |
Industry group Drugs | 455 out of 1,156 | 61st |
Industry Biological Products, Except Diagnostic Substances | 70 out of 196 | 64th |
Source: SEC filing on April 11, 2016.
Babu's colleagues
We found four more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2013.